Immunoassay
The ELISA and enzymatic techniques are the standards in neonatal screening. These techniques enable the detection of metabolic and endocrine diseases that may cause developmental delays, or even death, in infants. With early detection, prompt management can be implemented, thereby maximizing the newborn’s chances of growing and developing normally.
To cater for the needs of each type of laboratory, regardless of size, manual or automated kits are available.
The NEONATAL Biotinidase Screening Assay kit is an enzymatic test for biotinidase activity quantification.
The NEONATAL BTD Screening Fluo is an enzymatic assay designed to quantitatively measure biotinidase (BTD) activity levels in newborns, using dried blood spots, for the detection of biotinidase deficiency.
The NEONATAL 17-OHP Screening ELISA is a quantitative colorimetric enzyme immunoassay for newborn screening of congenital adrenal hyperplasia.
The NEONATAL 17-OHP Screening FLISA is a fluorescent enzyme immunoassay designed for the quantitative measurement of 17 alpha-hydroxyprogesterone (17-OHP).
The NEONATAL TOTAL-T4 Screening ELISA is a colorimetric enzyme immunoassay for the quantitative determination of total thyroxine (TT4).
The NEONATAL TSH Screening ELISA is a colorimetric enzyme immunoassay for the quantitative determination of thyroid stimulating hormone (TSH).
The NEONATAL TSH Screening FLISA is a fluorescent enzyme immunoassay designed for the quantitative measurement of thyroid stimulating hormone (TSH).
Cystic Fibrosis IRT
The NEONATAL IRT Screening ELISA is a colorimetric enzyme immunoassay for the quantitative determination of immunoreactive trypsinogen (IRT).
Colo
Cystic Fibrosis IRT
The NEONATAL IRT Screening FLISA is a fluorescent enzyme immunoassay for the quantitative determination of immunoreactive trypsinogen (IRT).
Fluo
Cystic Fibrosis PAP
The NEONATAL PAP Screening ELISA is a colorimetric enzyme immunoassay designed for the quantitative measurement of Pancreatitis-Associated Protein (PAP).
Colo
G6PD Deficiency
The NEONATAL G-6-PD Screening Assay is an enzymatic test in newborns for the quantification of glucose-6-phosphate dehydrogenase (G-6-PD) activity.
Colo
G6PD Deficiency
The NEONATAL G-6-PD Screening Fluo is an enzymatic assay designed for the precise quantitative measurement of G-6-PD activity, aiding in the detection of G-6-PD deficiency.
Fluo
Galactosemia GALT
The NEONATAL GAL-T Screening Fluo is an enzymatic assay for the quantitative determination of galactose-1-phosphate uridyltransferase (GAL-T) activity levels.
Fluo
Galactosemia TGAL
The NEONATAL Total-Galactose Screening Assay is an enzymatic test used to quantify total galactose (galactose and galactose-1-phosphate) as part of neonatal screening for galactosemia.
Colo
Galactosemia TGAL
The NEONATAL T-GAL Screening Fluo is an enzymatic test for the fluorescence detection of D-galactose and galactose-1-phosphate in the context of neonatal screening for galactosemia.
Fluo
The NEONATAL MSUD Screening Assay is a quantitative enzymatic test that assays leucine, isoleucine and valine, often called the branched-chain amino acids (BCAAs), that accumulate in maple syrup urine disease (MSUD) also known as ketoacidemia.
The NEONATAL MSUD Screening Fluo is an enzymatic test which enables the fluorescence detection of 3 amino acids (leucine, isoleucine and valine) accumulated in case of maple syrup urine disease (MSUD) in newborns.
Phenylketonuria
The NEONATAL PKU Screening Assay is a colorimetric enzyme assay used for phenylketonuria (PKU) newborn screening through the quantification of phenylalanine (Phe) concentration in dried blood sample of neonates on 903® or 226 blotting paper.
Colo
Phenylketonuria
The NEONATAL PKU Screening Fluo is an enzymatic test designed to screen newborns affected by phenylketonuria.
Fluo
DNA
Analysis Our DNA Analysis product line offers kits for the screening of Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiencies (SCID), either separately or combined in a single kit.
Analysis Our DNA Analysis product line offers kits for the screening of Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiencies (SCID), either separately or combined in a single kit.
Mass
spectrometry Our Mass Spectrometry product line offers high-performance kits designed for sample multiplexing, enabling fast results with exceptional sensitivity.
spectrometry Our Mass Spectrometry product line offers high-performance kits designed for sample multiplexing, enabling fast results with exceptional sensitivity.
Digital Microfluidics
Digital Microfluidics (DMF) is an advanced technology that allows the precise manipulation of microdroplets of liquids on a controlled electronic surface, without the need for channels or pumps like in traditional microfluidics.
You have a question regarding our products ? You want to know more about our method ?
Find out about our other expertises
Genetic testing
CE Kits
Pharmacogenetics
Genetic testing
CE Kits
Genetic predispositions and disorders
